"The source for European pharmaceutical biotechnology news..."
New Account

The Magazine

Current Issue

Looming patent cliffs and shrivelling pipelines have pharma's big players looking for new business models that will allow them to increase their bottom lines.

E-magazine
  • Previous Issues

Blog

Where our team of editors discuss what they think about the current NGP US Issues.

Marie Shields
Editor NGP Europe

Latest News

Resveratrol

GlaxoSmithKline defends anti-ageing drugs

Pharmaceutical giant GlaxoSmithKline has defended drugs, which it has financially backed, that...

read more
Comments
Allston Landing

Genzyme reports Q2 loss after inventory write-off

Genzyme, the US biotech firm that pharma giant Sanofi-Aventis is currently trying to purchase,...

read more
Comments
Novartis buys Alcon majority

Novartis Alcon deal approved by regulators

A deal that saw Swiss drugmaker Novartis buy a minority stake in Alcon has received approval from...

read more
Comments
The Shire

Shire profits increase for quarter

British drugmaker Shire, who is currently buying Belgian firm Movetis, has defied analysts’...

read more
Comments
MorphoSys

MorphoSys to receive Novartis milestone payout

German biotech company MorphoSys has announced that it is to receive a milestone payment from...

read more
Comments
To be bought by Sanofi-Aventis

Sanofi-Aventis to takeover Genzyme?

Industry reports indicate that pharmaceutical giant Sanofi-Aventis has approached the board of...

read more
Comments
Teva Pharmaceuticals

Teva profits up 53 percent

Teva Pharmaceutical, the global leader in the makers of generic drugs, has stated that its Q2...

read more
Comments
Pharma EU

The growth of HTS (Hit-throughput screening)

Back in May, it was announced that new stem cell research would reduce the need for animal...

read more
Comments
Trophos

Actelion to buy Trophos

Trophos, a French clinical stage pharmaceutical company, has been optioned to Swiss...

read more
Comments
Avandia

Avandia GlaxoSmithKline face £1.5bn legal bill

The pharma giant is reportedly set to face a legal charge of £1.57 billion for the second quarter...

read more
Comments

NGP Europe Summit: Drug Discovery

NGP Europe Summit: Drug Discovery
1st - 3rd September 2010

The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.